Bitcoin Rally, Salesforce Dividend, and the Ozempic Revolution 02/29/24

The bitcoin rally is showing no signs of slowing down. Standard Chartered's Geoff Kendrick and Ranger Equity Bear's David Tice debate the currency. Plus, Salesforce has issued a weaker-than-expected forecast but is initiating a $0.40 dividend. BNP Paribas Exane's Stefan Slowinski dives into the quarter. And, Ozempic and other GLP-1 drugs have disrupted the weight loss industry. Barclays' Emily Field explains. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.